Toxic shock syndrome in the United States: Surveillance update, 1979- 1996

Emerging Infectious Diseases

Volumn 5, Issue 6, 1999, Pages 807-810

  Hajjeh, Rana A ^a,c   Reingold, Arthur ^b   Weil, Alexis ^a   Shutt, Kathleen ^a   Schuchat, Anne ^a   Perkins, Bradley A ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; DESQUAMATION; EPIDEMIC; FEMALE; FEVER; HEALTH SURVEY; HUMAN; HYPOTENSION; MAJOR CLINICAL STUDY; MENSTRUATION; RASH; STAPHYLOCOCCUS AUREUS; TAMPON; TOXIC SHOCK SYNDROME; UNITED STATES;

EID: 0033373217     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid0506.990611     Document Type: Article

References (18)

1. U.S. Public Health Services. Addressing emerging infectious disease threats. A prevention strategy for the United States. Atlanta: Centers for Disease Control and Prevention; 1994.
2. Todd JK, Kapral FA, Fishaut M, Welch TR. Toxic shock syndrome associated with phage group 1 staphylococci. Lancet 1978;2:1116-8.
3. Centers for Disease Control and Prevention. Toxicshock syndrome - United States. MMWR Morb Mortal Wkly Rep 1980;29:229-30.
4. Broorne CV. Epidemiology of toxic shock syndrome in the United States: Overview. Reviews of Infect Diseases 1989:2 Suppl 1:S14-21.
5. Shands KN, Schmid GP, Dan BB, Blum D, Guidotti RJ, Hargrett NT, et al. Toxic-shock syndrome in menstruating women: association with tampon use and Staphylococcus aureus and clinical features in 52 cases. N Engl J Med 1980:303:1436-42.
6. Centers for Disease Control and Prevention. Toxic shock syndrome - United States. MMWR Morb Mortal Wkly Rep 1980:297-9.
7. Centers for Disease Control and Prevention. Follow-up on toxic-shock syndrome. MMWR Morb Mortal Wkly Rep 1980;29:441-5.
8. Reingold AL, Hargrett NT, Shands KN, Dan BB, Schmid GP, Strickland BY, et al. Toxic shock syndrome surveillance in the United States, 1980 to 1981. Ann Intern Med 1982;96 (part 2):875-80.
9. Gaventa S, Reingold AL, Hightower AW, Broome CV, Schwartz B, Hoppe C, et al. Active surveillance for toxic shock syndrome in the United States. 1986. Reviews of Infectious Diseases 1989:2 Suppl 1:S28-34.
10. Davis JP, Chesney PJ, Wand PJ, LaVenture M. Toxic-shock syndrome: epidemiologic features, recurrence, risk factors and prevention. N Engl J Med 1980:303:1429-35.
11. Latham RH, Kehrberg MW, Jacobson JA. Toxic shock syndrome in Utah: a case-control and surveillance study. Ann Intern Med 1982:96:906-8.
12. Schuchat A, Broome CV. Toxic shock syndrome and tampons. Epidemiol Rev 1991:13:99-112.
13. Centers for Disease Control and Prevention. Reduced incidence of menstrual toxic shock syndrome - United States, 1980-1990. MMWR Morb Mortal Wkly Rep 1990;39:421-4.
14. Petitti DB, Reingold AL. Update through 1985 on the incidence of toxic shock syndrome among members of a prepaid health plan. Reviews of Infectious Diseases 1989;11 Suppl 10:S22-7.
15. Schlievert PM. Comparison of cotton and cotton/rayon tampons for effect on production of toxic shock syndrome toxin. J Infect Dis 1995;172:1112-4.
16. Simonsen L, Conn LA, Pinner RW, Teutsch S. Trends in infectious disease hospitalizations in the United States, 1980-1994. Arch Intern Med 1998;158:1923-8.
17. Hughes D, Stapleton J. Postoperative toxic shock syndrome. Iowa Med 1991;81:55-8.
18. Lindsay J, Ruzin A, Ross HF, Kurepina N, Novick RP. The gene for toxic shock toxin is carried by a family of mobile pathogenicity islands in Staphylococcus aureus. Mol Microbiol 1998;29:527-43.